Evolution of the cancer genome.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Trends in Genetics

• Publication date

  2012-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tig.2012.01.003PMID 22342180PMCID PMC3711268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• High-order chromatin architecture shapes the landscape of chromosomal alterations in cancer

  2012cited by this paper
• A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

  2011cited by this paper
• Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3

  2011cited by this paper
• High-order chromatin architecture determines the landscape of chromosomal alterations in cancer

  2011cited by this paper
• Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging.

  2011cited by this paper
• Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

  2011cited by this paper
• Evolutionary mechanisms and diversity in cancer.

  2011cited by this paper
• Somatic retrotransposition alters the genetic landscape of the human brain

  2011cited by this paper
• Mutations in BRIP1 confer high risk of ovarian cancer

  2011cited by this paper
• Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.

  2011cited by this paper
• A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1

  2011cited by this paper
• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cited by this paper
• Somatic mosaicism in healthy human tissues.

  2011cited by this paper
• De novo constitutional MLH1 epimutations confer early‐onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one

  2011cited by this paper
• An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers

  2011cited by this paper
• Tumour evolution inferred by single-cell sequencing

  2011cited by this paper
• Predicting the functional impact of protein mutations: application to cancer genomics

  2011cited by this paper
• Genome sequencing reveals insights into physiology and longevity of the naked mole rat

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Hypomethylation of Intragenic LINE-1 Represses Transcription in Cancer Cells through AGO2

  2011cited by this paper
• DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes

  2011cited by this paper
• Future medical applications of single-cell sequencing in cancer

  2011cited by this paper
• A time-invariant principle of genome evolution

  2010cited by this paper
• Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia

  2010cited by this paper
• Elements of Evolutionary Genetics

  2010cited by this paper
• Tracing the tumor lineage

  2010cited by this paper
• Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

  2010cited by this paper
• Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer

  2010cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• Resistance to experimental tumorigenesis in cells of a long‐lived mammal, the naked mole‐rat (Heterocephalus glaber)

  2010cited by this paper
• ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

  2010cited by this paper
• Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.

  2010cited by this paper
• An integrated approach to uncover drivers of cancer.

  2010cited by this paper
• Molecular Evolutionary Analysis of Cancer Cell Lines

  2010cited by this paper
• Inferring tumor progression from genomic heterogeneity.

  2010cited by this paper
• DNA secondary structures and epigenetic determinants of cancer genome evolution

  2010cited by this paper
• The mutation spectrum revealed by paired genome sequences from a lung cancer patient

  2010cited by this paper
• Linking functional decline of telomeres, mitochondria and stem cells during ageing

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• The patterns and dynamics of genomic instability in metastatic pancreatic cancer

  2010cited by this paper
• Signatures of mutation and selection in the cancer genome

  2010cited by this paper
• JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

  2009cited by this paper
• Cancer epigenomics: Implications of DNA methylation in personalized cancer therapy

  2009cited by this paper
• A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms

  2009cited by this paper
• mRNA-Seq whole-transcriptome analysis of a single cell

  2009cited by this paper
• A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms

  2009cited by this paper
• Genome-scale DNA methylation maps of pluripotent and differentiated cells

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• The Catalogue of Somatic Mutations in Cancer (COSMIC)

  2008cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

  2007cited by this paper
• Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"

  2007cited by this paper
• The emerging landscape of breast cancer susceptibility

  2007cited by this paper
• Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"

  2007cited by this paper
• Genome-Wide Mapping of in Vivo Protein-DNA Interactions

  2007cited by this paper
• Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"

  2007cited by this paper
• Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases

  2007cited by this paper
• Genetic intra‐tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• Stochastic cancer progression driven by non‐clonal chromosome aberrations

  2006cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• Is cancer a disease of self-seeding?

  2006cited by this paper
• Problems in histological grading of malignancy and its clinical significance in patients with operable Breast Cancer

  2006cited by this paper
• BRCA1 promoter methylation predicts adverse ovarian cancer prognosis.

  2006cited by this paper
• The epigenetic progenitor origin of human cancer

  2006cited by this paper
• Genetic clonal diversity predicts progression to esophageal adenocarcinoma

  2006cited by this paper
• Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity

  2006cited by this paper
• Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

  2004cited by this paper
• TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.

  2004cited by this paper
• An integrated epigenetic and genetic approach to common human disease.

  2004cited by this paper
• Age-associated activation of epigenetically repressed genes in the mouse.

  2003cited by this paper
• Induction of Tumors in Mice by Genomic Hypomethylation

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Induction of Tumors in Mice by Genomic Hypomethylation

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• The molecular biology of chronic myeloid leukemia.

  2000cited by this paper
• Genetic instabilities in human cancers

  1998cited by this paper
• DNA hypomethylation leads to elevated mutation rates

  1998cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Clonal heterogeneity in breast cancer: Karyotypic comparisons of multiple intra—and extra—tumorous samples from 3 patients

  1995cited by this paper
• Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

  1994cited by this paper
• A codon-based model of nucleotide substitution for protein-coding DNA sequences.

  1994cited by this paper
• Punctuated equilibrium comes of age

  1993cited by this paper
• Homogeneity and heterogeneity in pancreas cancer: presence of predominant and minor morphological types and implications

  1986cited by this paper
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

  1985cited by this paper
• Hypomethylation distinguishes genes of some human cancers from their normal counterparts

  1983cited by this paper
• Punctuated equilibria: the tempo and mode of evolution reconsidered

  1977cited by this paper
• The clonal evolution of tumor cell populations.

  1976cited by this paper
• Mutation selection and the natural history of cancer

  1975cited by this paper
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

  1973cited by this paper
• Multiple-Mutation Theory of Carcinogenesis

  1958cited by this paper
• Zur Frage der Entstehung maligner Tumoren

  year unknowncited by this paper

• From intracellular drivers to immune modulators: emerging paradigms in oncogenic pathway-directed immunotherapy optimization

  2025cites this paper
• Autologous Nanovaccine Induces Immunogenic Domino Effect to Prevent Postoperative Recurrence of Orthotopic Glioblastoma

  2025cites this paper
• Liquid-liquid phase separation drives immune signaling transduction in cancer: a bibliometric and visualized study from 1992 to 2024

  2025cites this paper
• Immunotherapy for high-grade endometrial stromal sarcoma: a narrative review bridging molecular insights to clinical translation

  2025cites this paper
• Systematic review on the role of the gut microbiota in tumors and their treatment

  2024cites this paper
• Research Progress of CICs in Immunotherapy of Liver Cancer

  2024cites this paper
• Immunotherapy for head and neck cancer: Fundamentals and therapeutic development.

  2024cites this paper
• Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement

  2024cites this paper
• Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma

  2024cites this paper
• Emerging Gene-editing nano-therapeutics for Cancer

  2024cites this paper
• Nanomedicines Targeting Tumor Cells or Tumor-Associated Macrophages for Combinatorial Cancer Photodynamic Therapy and Immunotherapy: Strategies and Influencing Factors

  2024cites this paper
• Recent advances in AIE-based platforms for cancer immunotherapy.

  2024cites this paper
• Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically

  2023cites this paper
• Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management

  2023cites this paper
• SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric Cancer: Evidence from Expression, Functional, and Bioinformatic Analyses

  2023cites this paper
• Significant impact of redox regulation of estrogen‐metabolizing proteins on cellular stress responses

  2023cites this paper
• Cancer Immunotherapy: A Brief History, The Latest Development of Typical Subtypes and Therapy Combination

  2023cites this paper
• Early Breast Cancer Evolution by Autosomal Broad Copy Number Alterations

  2022cites this paper
• Association of graph-based spatial features with overall survival status of glioblastoma patients

  2022cites this paper
• Tumor immunomodulatory effects of polyphenols

  2022cites this paper
• Computational methods for analyzing RNA-sequencing contaminated samples and its impact on cancer genome studies

  2022cites this paper
• A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing

  2022cites this paper
• The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer

  2022cites this paper
• Head and neck squamous cell carcinoma: a potential therapeutic target for the Wnt signaling pathway

  2022cites this paper
• DNA in extracellular vesicles: from evolution to its current application in health and disease

  2022cites this paper
• Wnt ligand expression in malignant melanoma: new insights

  2022cites this paper
• M1 Polarized Tumor-Associated Macrophages (TAMs) as Promising Prognostic Signature in Stage I–II Gastric Adenocarcinomas

  2021cites this paper
• Pathogenic BRCA Variants as Biomarkers for Risk in Prostate Cancer

  2021cites this paper
• Signatures Beyond Oncogenic Mutations in Cell-Free DNA Sequencing for Non-Invasive, Early Detection of Cancer

  2021cites this paper
• CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies

  2021cites this paper
• The Immune Contexture and Cancer Therapy Aspects of the TIM-3 Checkpoint Pathway

  2021cites this paper
• Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects

  2021cites this paper
• FRL: An Integrative Feature Selection Algorithm Based on the Fisher Score, Recursive Feature Elimination, and Logistic Regression to Identify Potential Genomic Biomarkers

  2021cites this paper
• Two-phased evolution: Genome chaos-mediated information creation and maintenance.

  2021cites this paper
• Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution

  2021cites this paper
• CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model

  2021cites this paper
• CellCoal: Coalescent Simulation of Single-Cell Sequencing Samples

  2020cites this paper
• The evolution of hematopoietic cells under cancer therapy

  2020cites this paper
• Delineating the evolutionary dynamics of cancer from theory to reality

  2020cites this paper
• Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.

  2020cites this paper
• Punctuated Aneuploidization of the Budding Yeast Genome

  2020cites this paper
• Prognostic value of nucleotyping, DNA ploidy and stroma in high-risk stage II colon cancer

  2020cites this paper
• The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

  2020cites this paper
• Punctuated Aneuploidization of the Budding Yeast Genome

  2020cites this paper
• Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors

  2020cites this paper
• Technological Advancement in Cancer Stem Cell Research

  2020cites this paper
• Integrative Analysis of Dysfunctional Modules Driven by Genomic Alterations at System Level Across 11 Cancer Types.

  2019cites this paper
• Studying Cancer Heterogeneity by Single-Cell RNA Sequencing.

  2019cites this paper
• Molecular Profiles of Matched Primary and Metastatic Tumor Samples Support a Linear Evolutionary Model of Breast Cancer

  2019cites this paper
• Evolution of Stress-Induced Mutagenesis in the Presence of Horizontal Gene Transfer

  2019cites this paper
• From tumors to species: a SCANDAL hypothesis

  2019cites this paper
• Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma

  2019cites this paper
• The role of low-dose decitabine combined with chemotherapy in the treatment of recurrent and refractory gastric cancer : a single-center , single-arm clinical study

  2019cites this paper
• The Ecology of Cancer

  2019cites this paper
• Targeting the Hedgehog and Notch Signaling Pathways in Cancer Stem Cells

  2019cites this paper
• Histone deacetylase 6 expression in metastatic lymph nodes is a valuable prognostic marker for resected node-positive esophageal squamous cell cancer

  2018cites this paper
• Prognostic markers and therapeutic targets for metastatic renal cell carcinoma

  2018cites this paper
• Cytoprotective Effect of 120 Hz Electromagnetic Fields on Early Hepatocarcinogenesis: Experimental and Theoretical Findings

  2018cites this paper
• Heterogeneity-mediated cellular adaptation and its trade-off: searching for the general principles of diseases.

  2017cites this paper
• Mutator genomes decay, despite sustained fitness gains, in a long-term experiment with bacteria

  2017cites this paper
• Determining the role of inflammation in the selection of JAK2 mutant cells in myeloproliferative neoplasms.

  2017cites this paper
• Computational approach for deriving cancer progression roadmaps from static sample data

  2017cites this paper
• A Direct Test of Selection in Cell Populations Using the Diversity in Gene Expression within Tumors

  2017cites this paper
• Transmissible Cancer: The Evolution of Interindividual Metastasis

  2017cites this paper
• Chapter 5 – The Genomic Landscape of Cancers

  2017cites this paper
• Insights on processes of evolutionary tumor growth

  2017cites this paper
• Key issues review: evolution on rugged adaptive landscapes

  2017cites this paper
• The evolution of tumour phylogenetics: principles and practice

  2017influential citation
• Multidimensional extended spatial evolutionary games

  2016cites this paper
• The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process.

  2016cites this paper
• Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma

  2016cites this paper
• Heterogeneity Mediated System Complexity: The Ultimate Challenge for Studying Common and Complex Diseases

  2016cites this paper
• The Role of Theory in Cancer Research

  2016cites this paper
• Evolutionary Medicine I. An Overview and Applications to Cancer

  2016cites this paper
• Looking beyond drivers and passengers in cancer genome sequencing data.

  2016cites this paper
• Transmissible cancers in an evolutionary context

  2016cites this paper
• Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers

  2016cites this paper
• Classifying the Progression of Ductal Carcinoma from Single-Cell Sampled Data via Integer Linear Programming: A Case Study

  2016cites this paper
• Therapies targeting cancer stem cells: Current trends and future challenges.

  2015cites this paper
• Environmental pollutants leading to carcinogenesis: process of natural selection of human cells due to chronic inflammation and sustained stress environment

  2015influential citation
• A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events

  2015cites this paper
• A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types

  2015cites this paper
• Cancer Stem Cells: Plasticity Works against Therapy

  2015cites this paper
• 4th international conference on tumor progression and therapeutic resistance: meeting report

  2015cites this paper
• The prisoner's dilemma as a cancer model.

  2015cites this paper
• Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition

  2015cites this paper
• The evolution of drug resistance in clinical isolates of Candida albicans

  2015cites this paper
• IDENTIFICATION OF SYNTHETIC CYTOTOXIC INTERACTIONS TO IMPROVE THE EFFICACY OF DNA DAMAGING THERAPEUTIC AGENTS

  2014cites this paper
• Can a minimal replicating construct be identified as the embodiment of cancer?

  2014cites this paper
• Relative constraints and evolution

  2014cites this paper
• HaplotypeCN: Copy Number Haplotype Inference with Hidden Markov Model and Localized Haplotype Clustering

  2014cites this paper
• Cancer Evolution: Mathematical Models and Computational Inference

  2014cites this paper
• Patterns of somatically acquired amplifications and deletions in apparently normal tissues of ovarian cancer patients.

  2014cites this paper
• Cancer Evolution Is Associated with Pervasive Positive Selection on Globally Expressed Genes

  2014cites this paper
• Carcinogenicity and Teratogenicity Assessment

  2014cites this paper
• Cancer progression modeling using static sample data

  2014cites this paper
• From genomes to societies: a holistic view of determinants of human health.

  2014cites this paper
• Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome.

  2014cites this paper
• Stress-Induced Mutagenesis and Complex Adaptation

  2014cites this paper
• A ‘complex solution’ to a ‘complex’ problem: tackling the complexity of cancer with botanicals

  2014cites this paper